90 results
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... >10% (or >200 mL ... DLCO >15% (or 3 mL ... systemicsclerosis #SSc #pulmonary ... #indications #management
Pulmonary Embolism Therapies

Aligning therapeutic options with the severity of pulmonary embolism. Yellow boxes represent therapies requiring
Pulmonary Embolism ... in prospective clinical ... trials #Pulmonary ... Therapies #Severity #Management ... #Treatment
Alzheimer's Disease - Summary
 • Epidemiology
 • Pathophysiology
 • Risk Factors
 • Presentation
 • Diagnosis
 •
Epidemiology • Pathophysiology ... Diagnosis • Treatment ... • Clinical Course ... Summary #diagnosis #management
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Dobutamine 2-20 mcg ... Epinephrine 0-20 mcg ... Internet Book of Critical ... Pharmacology #Effect #Management
Massive Hemoptysis - Diagnosis and Management
 • Definitions: 
   - Hemoptysis = bleeding from
Diagnosis and Management ... bleeding (>1OO ml ... • Airway Management ... #treatment #workup ... #pulmonary #criticalcare
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Heart Failure Pathophysiology ... Ferritin <100 ng/mL ... Ferritin 100-299 ng/mL ... functional ID) Treatment ... heartfailure #diagnosis #management
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Thromboembolic Pulmonary ... embolism Pathophysiology ... Plexiform-lesion formation Clinical ... Bypass Other Treatment ... Thromboendarterectomy #diagnosis #management
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... blood donor • Pathophysiology ... : 33% • Treatment ... , and CXR with pulmonary ... : No • Treatment
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... accumulation of clinical ... Assessment • Clinical ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
Flail Chest- Check out the paradoxical chest wall movement 
Typical management: opiates for analgesia, intubation due
movement Typical management ... Pattern #Trauma #Video ... #Clinical #PhysicalExam ... #Pulmonary #Respiratory